A new grant to investigators in the Department of Global Health will support the generation of evidence to improve the care of acutely unwell, undernourished children. The initial phase of this project is funded by a $1.2 million award from Oxford University and it will fund the development of a number of clinical trials within a multi-site, multi-country platform (the Childhood Acute Illness & Nutritional (CHAIN) Network).
A recently-awarded grant from the National Institutes of Health (NIH) will allow Keshet Ronen, clinical assistant professor of Global Health, to develop natural language processing tools to use SMS text messaging to monitor and support maternal mental health in Kenya.
The grant, titled “Leveraging interactive SMS messaging to monitor and support maternal mental health in Kenya”, will fund Ronen’s research through May 2022 with a total award of $128,116. Ronen explained the purpose of this grant, as well as the public health impacts it can create.
With a new $765,120 grant, Global Health professor Paul Drain will lead a study to develop an antigen-based COVID-19 test – as well as evaluate PCR-based tests and immunological assays – to be used at the point of care. This grant, sponsored by the Bill and Melinda Gates Foundation, is titled “Developing and Evaluating Point-of-Care Antigen and Immunoassays for COVID-19 and Cytokine Release Syndrome among people being screened for SARS-CoV-2 infection in Seattle”.
With its Population Health Initiative, the University of Washington annually distributes research grant funding for one-of-a-kind projects that address unique health challenges here in Washington and around the world. This year, three of the awarded research teams include faculty members from the Department of Global Health: Peter Rabinowitz, Charles Mock, James Pfeiffer, Rachel Chapman, and Steve Gloyd.
Paul Drain—an Associate Professor in the Department of Global Health, Medicine and Epidemiology at the University of Washington—and his research team have received a new grant from the CoMotion Innovation Gap Fund, a program intended to help bridge the gap between academic research grants and the level of development needed to obtain investment. Drain’s project is titled “Rapid test for measuring adherence to antiretroviral therapy and pre-exposure prophylaxis”.
Gabrielle O’Malley, an Associate Professor of Global Health and Director of Implementation Science for the International Training and Education Center (I-TECH), received a $4,394,756 award to continue strengthening human resources for health in Malawi for HIV epidemic control and improved health outcomes of people living with HIV (PLHIV).
Lung cancer is far and away the leading cause of cancer deaths worldwide. In the U.S. alone, a projected 142,000 people will die of the disease this year.
The John E. Fogarty International Center and National Institutes of Health (NIH) have awarded a $900,000 grant to University of Washington global health professor Joseph Zunt. The grant will strengthen the Northern Pacific Global Health Research Training Consortium Program, which trains doctoral and post-doctoral fellows in the health profession.
Global Health Professor Receives $1.4 Million Grant to Study New Technologies in Tuberculosis Testing
A new grant from the Bill and Melinda Gates Foundation will allow Paul Drain, a professor in the UW Department of Global Health, to conduct clinical evaluation studies of point-of-care tuberculosis (TB) diagnostic tests. These rapid tests deliver quick results to patients and clinicians in hospital and community clinics. By accelerating the initiation of TB treatment, patients may have better outcomes and will be less likely to transmit TB to others. TB has become the leading infectious cause of mortality in the world, due partly to poorly performing diagnostic test practices.
Global Health Professor Receives Grant to Investigate Innovative Detection Methods to Eliminate Intestinal Worm Infections
Judd Walson, a University of Washington professor of Global Health, Medicine, and Pediatrics, recently received $621,029 in funding from the Bill and Melinda Gates Foundation for a research grant focused on the development of a molecular diagnostic platform for the detection of soil transmitted helminths (STH), commonly known as parasitic worms. Investigators will use these methods to support a large, multi-country, randomized trial evaluating the feasibility of interrupting STH transmission through expanded mass drug administration.